AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Clinical Study on Dry Needling for Primary Dysmenorrhea and Its Preliminary Correlation With Acupoints

RecruitingNAAges 18 Years - 30 YearsFemaleBeijing Hospital
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

Primary dysmenorrhea refers to menstrual pain not caused by pelvic organic lesions, commonly seen in young women, significantly affecting patients' quality of life. Dry needling therapy targeting myofascial trigger points for primary dysmenorrhea has been preliminarily applied in clinical settings. However, related research is limited with questionable quality, hindering its widespread clinical application. Furthermore, is there a connection between myofascial trigger points in dry needling and acupuncture acupoints in terms of selection and mechanism of action? Could this be a new interpretation of acupuncture theory? These are important questions that have garnered widespread attention. This study employs a randomized patient-blinded controlled design, enrolling primary dysmenorrhea patients aged 18 to 30 years. They are randomly divided into three groups: the trigger point dry needlin

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: 1. All participants diagnosed explicitly by a gynecologist as having primary dysmenorrhea without pelvic organic lesions. 2. Aged between 18 and 30 years. 3. A history of cyclical menstrual pain for more than 2 years. 4. Pain greater than 30mm on the Visual Analog Scale (VAS, 0-100mm). 5. Participants must sign an informed consent form and be willing to undergo acupuncture treatment and cooperate to complete the relevant procedures of this trial. Exclusion Criteria: 1. Those suffering from secondary dysmenorrhea or any other reproductive and urinary system diseases, such as endometriosis. 2. A history of pregnancy, miscarriage, or planning for pregnancy. Individuals with skin infections on the abdomen and lower back. 3. Past use of acupuncture therapy or other needling treatments. 4. Those with a history of mental illness and severe diseases of the heart, liver, brain, kidneys, hematopoietic system, etc. 5. Within the past 6 months, individuals referred to pain clinics, those who have used pain relievers like morphine or pethidine, or those allergic to NSAIDs. Also, those currently taking or receiving anticoagulant medications. 6. Individuals who have had adverse reactions to acupuncture (e.g., fainting).
๐Ÿ’Š

What it tests

  • TrP-DN and Acupuncture
๐Ÿ“

Where

2 sites
Yanxia Sun
Beijing, China
Yanxia Sun
Beijing, China
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy